Immunoglobulin Fc Heterodimer Platform Technology: From Design to Applications in Therapeutic Antibodies and Proteins
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunoglobulin Fc Heterodimer Platform Technology: From Design to Applications in Therapeutic Antibodies and Proteins
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 7, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2016-10-06
DOI
10.3389/fimmu.2016.00394
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Abstract CT050: A Phase I/II Study of MCLA-128, a full length IgG1 Bispecific Antibody Targeting HER2 and HER3, in Patients with Solid Tumors
- (2016) Emiliano Calvo et al. CANCER RESEARCH
- A Novel Bispecific Antibody Targeting EGFR and cMet Is Effective against EGFR Inhibitor–Resistant Lung Tumors
- (2016) Sheri L. Moores et al. CANCER RESEARCH
- A Novel Carcinoembryonic Antigen T-Cell Bispecific Antibody (CEA TCB) for the Treatment of Solid Tumors
- (2016) M. Bacac et al. CLINICAL CANCER RESEARCH
- Immunocytokines for cancer treatment: past, present and future
- (2016) Dario Neri et al. CURRENT OPINION IN IMMUNOLOGY
- Immunocytokines and bispecific antibodies: two complementary strategies for the selective activation of immune cells at the tumor site
- (2016) Jonathan D. Kiefer et al. IMMUNOLOGICAL REVIEWS
- Blinatumomab: a CD19/CD3 bispecific T cell engager (BiTE) with unique anti-tumor efficacy
- (2016) Maria-Elisabeth Goebeler et al. LEUKEMIA & LYMPHOMA
- XGFR*, a novel affinity-matured bispecific antibody targeting IGF-1R and EGFR with combined signaling inhibition and enhanced immune activation for the treatment of pancreatic cancer
- (2016) Juergen M. Schanzer et al. mAbs
- The use of CrossMAb technology for the generation of bi- and multispecific antibodies
- (2016) Christian Klein et al. mAbs
- Factor VIII–Mimetic Function of Humanized Bispecific Antibody in Hemophilia A
- (2016) Midori Shima et al. NEW ENGLAND JOURNAL OF MEDICINE
- Computationally Designed Bispecific Antibodies using Negative State Repertoires
- (2016) Andrew Leaver-Fay et al. STRUCTURE
- Immunoglobulin Transporting Receptors Are Potential Targets for the Immunity Enhancement and Generation of Mammary Gland Bioreactor
- (2016) Xuemei Jiang et al. Frontiers in Immunology
- Humanization of a phosphothreonine peptide-specific chicken antibody by combinatorial library optimization of the phosphoepitope-binding motif
- (2015) Du-San Baek et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Fusion Proteins for Half-Life Extension of Biologics as a Strategy to Make Biobetters
- (2015) William R. Strohl BIODRUGS
- Synergistic Innate and Adaptive Immune Response to Combination Immunotherapy with Anti-Tumor Antigen Antibodies and Extended Serum Half-Life IL-2
- (2015) Eric F. Zhu et al. CANCER CELL
- Bispecific antibodies
- (2015) Roland E. Kontermann et al. DRUG DISCOVERY TODAY
- A Novel Antibody Engineering Strategy for Making Monovalent Bispecific Heterodimeric IgG Antibodies by Electrostatic Steering Mechanism
- (2015) Zhi Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Immunoglobulin Fc-fused, neuropilin-1-specific peptide shows efficient tumor tissue penetration and inhibits tumor growth via anti-angiogenesis
- (2015) Ye-Jin Kim et al. JOURNAL OF CONTROLLED RELEASE
- Bispecific antibodies and their applications
- (2015) Gaowei Fan et al. Journal of Hematology & Oncology
- Fab-based bispecific antibody formats with robust biophysical properties and biological activity
- (2015) Xiufeng Wu et al. mAbs
- Crystal structures of immunoglobulin Fc heterodimers reveal the molecular basis for heterodimer formation
- (2015) Hye-Ji Choi et al. MOLECULAR IMMUNOLOGY
- Molecular properties of human IgG subclasses and their implications for designing therapeutic monoclonal antibodies against infectious diseases
- (2015) Vashti Irani et al. MOLECULAR IMMUNOLOGY
- Alternative molecular formats and therapeutic applications for bispecific antibodies
- (2015) Christoph Spiess et al. MOLECULAR IMMUNOLOGY
- Engineering of Immunoglobulin Fc Heterodimers Using Yeast Surface-Displayed Combinatorial Fc Library Screening
- (2015) Hye-Ji Choi et al. PLoS One
- Antigen specificity can be irrelevant to immunocytokine efficacy and biodistribution
- (2015) Alice Tzeng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fc fusion as a platform technology: potential for modulating immunogenicity
- (2015) Ditza Levin et al. TRENDS IN BIOTECHNOLOGY
- Exploiting light chains for the scalable generation and platform purification of native human bispecific IgG
- (2015) Nicolas Fischer et al. Nature Communications
- Abstract 2579: Combination with the novel tumor-targeted CEA-IL2v immunocytokine enhances the activity of ADCC-competent and glycoengineered antibodiesin vitroandin vivo
- (2015) Valeria Nicolini et al. CANCER RESEARCH
- Four-in-One Antibodies Have Superior Cancer Inhibitory Activity against EGFR, HER2, HER3, and VEGF through Disruption of HER/MET Crosstalk
- (2014) S. Hu et al. CANCER RESEARCH
- A Novel Glycoengineered Bispecific Antibody Format for Targeted Inhibition of Epidermal Growth Factor Receptor (EGFR) and Insulin-like Growth Factor Receptor Type I (IGF-1R) Demonstrating Unique Molecular Properties
- (2014) Juergen M. Schanzer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Construction of a Large Synthetic Human Fab Antibody Library on Yeast Cell Surface by Optimized Yeast Mating
- (2014) Du-San Baek et al. JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY
- Antiparallel Conformation of Knob and Hole Aglycosylated Half-Antibody Homodimers Is Mediated by a CH2–CH3 Hydrophobic Interaction
- (2014) J.Michael Elliott et al. JOURNAL OF MOLECULAR BIOLOGY
- Production of bispecific antibodies in “knobs-into-holes” using a cell-free expression system
- (2014) Yiren Xu et al. mAbs
- Generation of bispecific IgG antibodies by structure-based design of an orthogonal Fab interface
- (2014) Steven M Lewis et al. NATURE BIOTECHNOLOGY
- Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates
- (2014) Y. J. Yu et al. Science Translational Medicine
- IgG Subclasses and Allotypes: From Structure to Effector Functions
- (2014) Gestur Vidarsson et al. Frontiers in Immunology
- Antitumor Immunity: Easy as 1, 2, 3 with Monoclonal Bispecific Trifunctional Antibodies?
- (2013) J. Maher et al. CANCER RESEARCH
- Targeting T cells to tumor cells using bispecific antibodies
- (2013) Stanley R Frankel et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- IBC’s 23rd Annual Antibody Engineering, 10th Annual Antibody Therapeutics International Conferences and the 2012 Annual Meeting of The Antibody Society
- (2013) Peter-Christian Klöhn et al. mAbs
- Knobs-into-holes antibody production in mammalian cell lines reveals that asymmetric afucosylation is sufficient for full antibody-dependent cellular cytotoxicity
- (2013) Whitney Shatz et al. mAbs
- Production of stable bispecific IgG1 by controlled Fab-arm exchange
- (2013) Michael J Gramer et al. mAbs
- Improving biophysical properties of a bispecific antibody scaffold to aid developability
- (2013) Thomas Spreter Von Kreudenstein et al. mAbs
- Protein engineering and the use of molecular modeling and simulation: The case of heterodimeric Fc engineering
- (2013) Thomas Spreter Von Kreudenstein et al. METHODS
- A Heterodimeric Fc-Based Bispecific Antibody Simultaneously Targeting VEGFR-2 and Met Exhibits Potent Antitumor Activity
- (2013) H.-J. Choi et al. MOLECULAR CANCER THERAPEUTICS
- Crystal structure of a novel asymmetrically engineered Fc variant with improved affinity for FcγRs
- (2013) F. Mimoto et al. MOLECULAR IMMUNOLOGY
- Bispecific antibodies with natural architecture produced by co-culture of bacteria expressing two distinct half-antibodies
- (2013) Christoph Spiess et al. NATURE BIOTECHNOLOGY
- Identification and Multidimensional Optimization of an Asymmetric Bispecific IgG Antibody Mimicking the Function of Factor VIII Cofactor Activity
- (2013) Zenjiro Sampei et al. PLoS One
- Efficient generation of stable bispecific IgG1 by controlled Fab-arm exchange
- (2013) A. F. Labrijn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Monovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agent
- (2013) M. Merchant et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Structural Basis of Antibody-Antigen Recognition
- (2013) Inbal Sela-Culang et al. Frontiers in Immunology
- Antibody–cytokine fusion proteins
- (2012) Roland E. Kontermann ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- The Antibody-Based Delivery of Interleukin-12 to the Tumor Neovasculature Eradicates Murine Models of Cancer in Combination with Paclitaxel
- (2012) N. Pasche et al. CLINICAL CANCER RESEARCH
- Fc-fusion proteins: new developments and future perspectives
- (2012) Daniel M. Czajkowsky et al. EMBO Molecular Medicine
- Soluble Monomeric IgG1 Fc
- (2012) Tianlei Ying et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Generating Bispecific Human IgG1 and IgG2 Antibodies from Any Antibody Pair
- (2012) Pavel Strop et al. JOURNAL OF MOLECULAR BIOLOGY
- A novel bispecific antibody format enables simultaneous bivalent and monovalent co-engagement of distinct target antigens
- (2012) Gregory L. Moore et al. mAbs
- Progress in overcoming the chain association issue in bispecific heterodimeric IgG antibodies
- (2012) Christian Klein et al. mAbs
- Dual targeting strategies with bispecific antibodies
- (2012) Roland Kontermann mAbs
- IL-12 family cytokines: immunological playmakers
- (2012) Dario A A Vignali et al. NATURE IMMUNOLOGY
- A bispecific antibody to factors IXa and X restores factor VIII hemostatic activity in a hemophilia A model
- (2012) Takehisa Kitazawa et al. NATURE MEDICINE
- Molecular characterization of novel trispecific ErbB-cMet-IGF1R antibodies and their antigen-binding properties
- (2012) R. Castoldi et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Cloning and characterization of novel tumor-targeting immunocytokines based on murine IL7
- (2011) Nadine Pasche et al. JOURNAL OF BIOTECHNOLOGY
- Immunoglobulin domain crossover as a generic approach for the production of bispecific IgG antibodies
- (2011) W. Schaefer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Therapeutic assessment of SEED: a new engineered antibody platform designed to generate mono- and bispecific antibodies
- (2011) M. Muda et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Boosting Brain Uptake of a Therapeutic Antibody by Reducing Its Affinity for a Transcytosis Target
- (2011) Y. J. Yu et al. Science Translational Medicine
- Structure and function of immunoglobulins
- (2010) Harry W. Schroeder et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Development of a Two-part Strategy to Identify a Therapeutic Human Bispecific Antibody That Inhibits IgE Receptor Signaling
- (2010) Janet Jackman et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Enhancing Antibody Fc Heterodimer Formation through Electrostatic Steering Effects
- (2010) Kannan Gunasekaran et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- SEEDbodies: fusion proteins based on strand-exchange engineered domain (SEED) CH3 heterodimers in an Fc analogue platform for asymmetric binders or immunofusions and bispecific antibodies†
- (2010) Jonathan H. Davis et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Receptor-Fc fusion therapeutics, traps, and MIMETIBODY™ technology
- (2009) Chichi Huang CURRENT OPINION IN BIOTECHNOLOGY
- Biodistribution of a Bispecific Single-chain Diabody and Its Half-life Extended Derivatives
- (2009) Roland Stork et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Expression of soluble and functional human neonatal Fc receptor in Pichia pastoris
- (2009) Chang-Han Lee et al. PROTEIN EXPRESSION AND PURIFICATION
- Variants of the Antibody Herceptin That Interact with HER2 and VEGF at the Antigen Binding Site
- (2009) J. Bostrom et al. SCIENCE
- Specificity and affinity of human Fc receptors and their polymorphic variants for human IgG subclasses
- (2008) P. Bruhns et al. BLOOD
- Tumor Regression in Cancer Patients by Very Low Doses of a T Cell-Engaging Antibody
- (2008) R. Bargou et al. SCIENCE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now